диссертации / 84

327.Phan, B.A., Toth, P.P. Dyslipidemia in women: etiology and management // Int J Womens Health. - 2014. -№6. -Р.85-94.

328.Pinilla, L. Regulation of serum leptin levels by gonadal function in rats / Pinilla L, Seoane LM, Gonzalez L, et al.//Eur J Endocrinol. - 1999. -№140.

-Р.468–73.

329. Pischon, T. General and abdominal adiposity and risk of death in Europe. /Pischon T, Boeing H, Hoffmann K, et al.//N Engl J Med. - 2008. -

№359. -Р.2105–2120.

330.Pizzi, O. Pulse wave velocity, blood pressure and adipocytokines in

young adults: the Rio de Janeiro study / Pizzi OL, Brandão AA, Pozzan R, et

al. // Arq Bras Cardiol. - 2013. -№ 100(1). -Р.60-6.

331.Poirier, P. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association /Poirier P, Alpert MA, Fleisher LA, et al.// Circulation. - 2009. -№120. -Р.86 – 95.

332.Poirier, P. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update / Poirier P., Giles T.D., Bray G.A., et al. // Circulation. - 2006. -№113. -Р.898–918

333.Pope, J. Missed diagnoses of acute cardiac ischemia in the emergency department / Рope JH, Aufderheide JP, Ruthazer R, et al.//N Engl J Med. - 2000. -№342. -Р.1163–70.

334.Prescott, E. Smoking and risk of myocardial infarction in women and men: longitudinal population study/Prescott E, Hippe M, Schnohr P, et al. // BMJ.-1998. -№ 316. -Р.1043 – 1047.

335.Quinkler, M. Androgen generation in adipose tissue in women with simple obesity–a sitespecific role for 17beta-hydroxysteroid dehydrogenase type 5. /Quinkler M, Sinha B, Tomlinson JW, et al. //J Endocrinol. -2004. -

№183. -Р.331–342.

336. Reaven, GM. Insulin resistance and human disease: a short history//J Basic Clin Physiol Pharmacol. - 1998. -№9(2-4). - Р. 387-406.

271

337.Regitz-Zagrosek, V, Lehmkuhl, E, Mahmoodzadeh, S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease // Gend Med 2007. -№ 4(suppl). -Р.S162–S177.

338.Reiner, Z. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) /Reiner Z., Catapano A., De Backer G., et al. // European Heart Journal. - 2011. -№ 32. -Р.1769–1818.

339.Retnakaran, R. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women / Retnakaran R, Ying Q, Zinman B,et al.// J Clin Endocrinol Metab. - 2010. -№95.-Р.670–7.

340.Rich-Edwards, J. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? /Rich-Edwards JW, Fraser A, Lawlor DA,et al. //Epidemiol Rev. -2014. -№36

(1). -Р.57-70.

341.Ross, RL, Serock, MR, Khalil, RA. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease. Curr Cardiol Rev.- 2008. -№4. -Р.309 – 22.

342.Ryan, MC. Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease / Ryan MC, Fenster Farin HM, Abbasi F, et al.//Am J Cardiol. - 2008.-№102.-Р.40–6.

343.Rydén, L. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European

Association for the Study of Diabetes (EASD) / Rydén L, Grant PJ, Anker

SD, et al. // Eur Heart J. - 2013. -№34(39). -Р.3035-87.

272

344.Saba, S. Effects of estrogen on cardiac electrophysiology in female mice/Saba S, Zhu W, Aronovitz MJ, et al. // J Cardiovasc Electrophysiol. - 2002. -№13. -Р.276 – 280.

345.Satoh, H, Kishi, R, Tsutsui, H. Body mass index can similarly predict the presence of multiple cardiovascular risk factors in middle-aged Japanese subjects as waist circumference//Intern Med 2010. -№49.-Р.977–82.

346.Saunders, T. Acute sedentary behaviour and markers of cardiometabolic risk: a systematic review of intervention studies / Saunders TJ, Larouche R, Colley RC, et al.// J Nutr Metab. - 2012. -№2012. - Р.712435.

347.Schernthaner, G. Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR // Wien Med Wochenschr. - 2010. -№160 (1-2). -Р.8-19.

348.Schneider, H. Accuracy of anthropometric indicators of obesity to predict cardiovascular risk /Schneider HJ, Glaesmer H, Klotsche J, et al. //J Clin Endocrinol Metab. - 2007. -№92. -Р.589–94.

349.Sebo, P. Reliability of doctors’ anthropometric measurements to detect

obesity / Sebo P, Beer-Borst S, Haller DM, et al. // Prev Med. - 2008. -№47.

-№389 – 393.

350.Shai, I. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines / Shai I, Rimm EB, Hankinson SE, et al. // Circulation. - 2004. -№110. -Р.2824 – 2830.

351.Shaw, L. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival / Shaw LJ, Bairey Merz CN,et al. // J Clin Endocrinol Metab. - 2008. -№93. -Р.1276–1284.

352.Shaw, L. Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and nonobstructive

273

coronary artery disease. /Shaw LJ, Min JK, Narula J,et al.//Circ Cardiovasc Imaging. - 2010. -№3. -Р.473 – 81.

353. Shaw, LJ, Bugiardini, R, Bairey Merz, CN. Women and ischemic heart disease. Evolving knowledge // J Am Coll Cardiol. - 2009. -№54. -Р.1561–

1575.

354.Siontis, G. Comparisons of established risk prediction models for cardiovascular disease: systematic review / Siontis GC, Tzoulaki I, Siontis KC, et al. // BMJ. - 2012. - №24(344). - e3318.

355.Sowers, MR. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone treated women at midlife / MR. Sowers, J Jr. Randolph, Jannausch M., et al. // Arch Intern Med. - 2008. -№168. - Р.21462153.

356.Spring, B. Healthy lifestyle change and subclinical atherosclerosis in young adults: Coronary Artery Risk Development in Young Adults (CARDIA) study /Spring B, Moller AC, Colangelo LA, et al.// Circulation. - 2014.-№1-Vol.130(1). -P.10-7.

357.Staessen, J. Menopause and the characteristics of the large arteries in a population study/Staessen JA, van der Heijden-Spek JJ, Safar ME, et al.// J Hum Hypertens. - 2001. -№15. -Р.511 – 518.

358.Stamler, J. INTERSALT study findings. Public health and medical care implications/Stamler J., Rose G., Stamler R., et al.// Hypertension. - 1989. -

№14(5). -Р.570–7.

359.Standards of Medical Care in Diabetes—2010. American Diabetes Association // Diabetes Care. - 2010. -№33(Suppl. 1). -Р.S11–S61.

360.Stein, J. Smoking Cessation and the Risk of Diabetes Mellitus and Impaired Fasting Glucose: Three-Year Outcomes after a Quit Attempt / Stein JH, Asthana A, Smith SS, et al. // PLoS ONE. - 2014. -№9(6). -Р.e98278.

361.Stewart, ST, Cutler, DM, Rosen, AB. Forecasting the effects of obesity and smoking on U.S. life expectancy//N Engl J Med. - 2009. -№361 .Р.2252

– 2260.

274

362.Stone, N. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults 2013 : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines / Stone NJ, Robinson J, Lichtenstein AH, et al. // Circulation. - 2013.-№00. - Р.000–000.

363.Stramba-Badiale, M. Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project// Eur Heart J. - 2010. -№31. -Р.1677–1681

364.Strategy for Europe on nutrition, overweight and obesity related health issues: Implementation progress report. - WHO, 2010. - 36 p.

365.Strehlow, K. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation / Strehlow K, Werner N, Berweiler J, et al.// Circulation. - 2003. -№107. -Р.3059 – 3065.

366.Taylor, A. Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. /Taylor AE, Ebrahim S, Ben-Shlomo Y, et al.//Am J Clin Nutr. - 2010. -№91. Р.547 – 556.

367.The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease // JAMA. - 2009. -№ 302 (18). -

Р.1993–2000.

368.The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Guidelines on cardiovascular disease prevention in clinical practice// European Heart Journal. -2012. -№ 33. -Р.1635–1701.

369.The Global Burden of Noncommunicable Diseases: population studies. - Pfizer primary care, 2011. - 22p.

370.The Rotterdam ESHRE/ASRM-Sponsored consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks

275

related to polycystic ovary syndrome (PCOS)//Hum Reprod. -2004. -№ 19. -

Р.41–47.

371. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report/Chobanian AV, Bakris GL, Black HR, et al.// JAMA. - 2003. -№289. -

Р.2560 – 2572.

372. Towfighi, A, Zheng, L, Ovbiagele, B. Sex-specific trends in midlife coronary heart disease risk and prevalence//Arch Intern Med. - 2009. -№169.

-Р.1762 – 1766.

373.Tsounis, D. High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death? /Тsounis D, Deftereos S, Bouras G, et al. //Curr Top Med Chem. -2013.-№13(2).-Р.201-15.

374.Turkbey, E. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA)/Turkbey EB, McClelland RL, Kronmal RA, et al. //JACC Cardiovasc Imaging. - 2010. -№3(3). -Р.266-274.

375.Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation (WHO/NMH/CHP/CPM/11.1). - World Health Organization, 2011.-р.

376.Vaccarino, V. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? /Vaccarino V., Badimon L., Corti R., et al. //Cardiovascular Research. - 2011. -№ 90. -Р.9–17.

377.Van der Giezen, AM. Systolic blood pressure and cardiovascular mortality among 13,740 Dutch women /van der Giezen AM, SchopmanGeurts van Kessel JG, Schouten EG, et al.// Prev Med. - 1990. -№19. -Р.456

– 465.

378.Van der Meer, I. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study/van der Meer IM, Iglesias del Sol A, Hak AE, et al.//Stroke. - 2003. -№34(10). -

Р.2374-9.

276

379.Van Dis, I. Body mass index and waist circumference predict both 10year nonfatal and fatal cardiovascular disease risk: study conducted in 20 000 Dutch men and women aged 20–65 years/van Dis I, Kromhout D, Geleijnse JM, et al.//Eur J Cardiovasc Prev Rehabil. - 2009. -№16. -Р.729–34

380.Vasan R. Impact of high-normal blood pressure on the risk of cardiovascular disease/Vasan RS, Larson MG, Leip EP, et al.// N Engl J Med. - 2001. -№345. - Р.1291 –7.

381.Vazquez, G. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis/Vazquez G, Duval S, Jacobs DR Jr, et al.// Epidemiol Rev. - 2007. -№29. -Р.115 – 128.

382.Villar, IC, Hobbs, AJ, Ahluwalia, A. Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor// J Endocrinol. - 2008. -№197. -Р.447 – 62.

383.Von Känel, R, Orth-Gomér, K. Autonomic function and prothrombotic

activity in women after an acute coronary event// J Womens Health. - 2008. -

№17. -Р.1331–1337.

384.Von Mering, G. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women/von Mering GO, Arant CB, Wessel TR, et al.// Circulation. - 2004. -№109. -Р.722 – 725.

385.Walsh, JM, Pignone, M. Drug treatment of hyperlipidemia in women// JAMA. - 2004. -№291. -Р.2243 – 52.

386.Wang, J, Bingaman, S, Huxley, VH. Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases//Am J Physiol Heart Circ Physiol. - 2010. -№298. -Р.H1146 – 1154.

387.Wannamethee, S. Decreased muscle mass and increased central adiposity are independently related to mortality in older men/Wannamethee SG, Shaper AG, Lennon L, et al.//Am J Clin Nutr. - 2007. -№86. -Р.1339 –

1346.

277

388. Wehr, E. Subcutaneous Adipose Tissue Topography and Metabolic Disturbances in Polycystic Ovary Syndrome/Wehr E, Mo ̈ller R, Horejsi R, et al.// Wien Klin Wochenschr. - 2009. -№ 121.-Р. 262–269.

389.Wehr, E. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women/Wehr E, Gruber HJ, Giuliani A, et al.//J Clin Endocrinol Metab. - 2011. -№96. -Р.E986–990.

390.Wellons, M. Cardiovascular disease and primary ovarian insufficiency//Semin Reprod Med. - 2011. -№29(4). -Р.328-41.

391.Whitcroft, S, Herriot, A. Insulin resistance and management of the menopause: a clinical hypothesis in practice // Menopause Int. - 2011. -№

17(1). - Р.24-8.

392.Whitlock, G. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies/Whitlock G, Lewington S, Sherliker P, et al. // Lancet. - 2009. -№373. - Р.1083 – 96.

393.Wild, R. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society/Wild RA, Carmina E, Diamanti-Kandarakis E, et al.// J Clin Endocrinol Metab. -2010. -№95. -Р.2038–49.

394.Willett W. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes / Willett WC, Green A, Stampfer MJ, et al.// N Engl J Med. - 1987. -№317. -Р.1303 – 1309.

395.Willi, C. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis / Willi C, Bodenmann P, Ghali WA, et al. // JAMA. - 2007. -№298. -р.2654–2664.

396.Wilmot, E., Idris, I. Early onset type 2 diabetes: risk factors, clinical impact and management // Ther Adv Chronic Dis. - 2014. - № 5(6). -Р.234–

244.

278

397.Wilson, P. Clustering of metabolic factors and coronary heart

disease/Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB.// Arch

Intern Med - 1999. -№159.-Р.1104 – 9.

398.Winter, Y. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks/Winter Y, Rohrmann S, Linseisen J, et al. //Stroke. - 2008. -№39. -Р.3145–51.

399.Wittchen, H-U. International day for the evaluation of abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries/Wittchen H-U, Balkau B, Massien C, et al. // Eur Heart J Suppl.- 2006. -№8(Suppl B).-

Р.B26–33.

400.Women and health: today's evidence tomorrow's agenda. - Geneva: World Health Organization, 2009. - 91p.

401.Women and smoking: a report of the surgeon general. Executive summary// MMWR Recomm Rep. - 2002. -№51(RR-12). -Р.1 – 13.

402.Wong, N. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III/Wong ND, Pio J, Valencia R, Thakal G. // Prev Cardiol.-2001. -№4. -Р.109 – 114.

403.Wood, DA. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial/Wood DA, Kotseva K, Connolly S, et al.// Lancet. - 2008. -№371. -Р.1999 – 2012.

404.Woodiwiss, A. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure/Woodiwiss AJ, Libhaber CD, Majane OH, et al.// Am J Hypertens.- 2008.-№21(10).-Р.1144-51.

405.World Health Organization. [Электронный ресурс] //Режим доступа:

http://www.who.int

279

406.World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation/World Health Organization Technical Report Series. - Report No. 894. -1998.-231р.

407.World health statistics 2009. - Geneva: World Health Organization Press, 2009. - 149p.

408.World health statistics 2012. - Geneva: World Health Organization Press, 2012. - 97p.

409.World health statistics 2014. Geneva: World Health Organization Press, 2014. - 149p.

410.Wormser, D. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies/Wormser D, Kaptoge S, Di Angelantonio E, et al.//Lancet. - 2011. -№377(9771). -Р.1085-95.

411.Yasmin, E., Balen, A.H., Barth, J.H. he association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome // Eur J Obstet Gynecol Reprod Biol. - 2013. - №166(2). -

Р.173-7.

412.Yildiz, B. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria/Yildiz BO, Bozdag G, Yapici Z, et al.// Hum Reprod. -2012. -№27. -Р.3067–3073.

413.Ying, X. Body mass index, waist circumference, and cardiometabolic risk factors in young and middle-aged Chinese women/Ying X, Song Z, Zhao C, et al. // J Zhejiang Univ Sci B. - 2010. -№11. -Р.639–46.

414.Yusuf, S. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study/Yusuf S, Hawken S, Ounpuu S, et al. // Lancet. - 2004. -№364. -Р.937

– 952.

415.Yusuf, S. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study/Yusuf S, Hawken S,

Ôunpuu S, et al. // Lancet. -2005. -№366. -Р.1640–9.

280